BioCentury
ARTICLE | Company News

BioNumerik, Asta Medica Oncology deal

February 26, 2001 8:00 AM UTC

The companies will co-develop BioNumerik's BNP7787 chemoprotectant worldwide except in the U.S., Canada and Japan. Asta will have exclusive marketing rights in those territories, and BioNumerik recei...